Smoking cessation programmes
typically provide a six- to seven-week
programme of support, including
pharmacological treatments like NRT
or drugs like varenicline (marketed
as Champix® in the UK), alongside
behavioural support to help patients
plan for life without smoking —
this usually includes identifying
improvements to their health and
monitoring their cessation through
carbon monoxide measuring
(using a small hand-held device
that measures the amount carbon
monoxide as the patient exhales), as
well as relapse prevention.